![Matthew Norkunas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Norkunas
Directeur/Bestuurslid bij
Obsidian Therapeutics, Inc.
Vermogen: 541 707 $ op 31-08-2026
Profiel
Matthew Norkunas currently works at Obsidian Therapeutics, Inc., as Director from 2023 and Obsidian Therapeutics, Inc., as Director from 2026.
Dr. Norkunas also formerly worked at Marsico Capital Management LLC, as Research Analyst from 2012 to 2013, SomaLogic Operating Co., Inc., as Chief Financial Officer from 2016 to 2020, and Generation Bio Co., as Chief Financial & Accounting Officer.
Dr. Norkunas received his undergraduate degree in 1999 from St. Mary's College (Maryland), doctorate degree from the University of Maryland School of Medicine, and Masters Business Admin degree from Columbia Business School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,05% | 03-08-2026 | 30.937 ( 0,05% ) | 541 707 $ | 31-08-2026 |
Actieve functies van Matthew Norkunas
| Bedrijven | Functie | Begin |
|---|---|---|
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Directeur/Bestuurslid | 23-05-2023 |
Eerdere bekende functies van Matthew Norkunas
| Bedrijven | Functie | Einde |
|---|---|---|
| GENERATION BIO CO. | Financieel Directeur/CFO | 10-01-2025 |
SomaLogic Operating Co., Inc.
 SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology Operates as a protein biomarker discovery and clinical diagnostics company | Financieel Directeur/CFO | 01-06-2020 |
Marsico Capital Management LLC
 Marsico Capital Management LLC Investment ManagersFinance MCM seeks to combine the early identification of long-term secular themes with rigorous fundamental research to identify high-quality companies with exceptional long-term growth potential. The firm blends top-down macroeconomic analysis and theme development with bottom-up stock selection. | Analyst-Equity | - |
Opleiding van Matthew Norkunas
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
56
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Marsico Capital Management LLC
Marsico Capital Management LLC Investment ManagersFinance MCM seeks to combine the early identification of long-term secular themes with rigorous fundamental research to identify high-quality companies with exceptional long-term growth potential. The firm blends top-down macroeconomic analysis and theme development with bottom-up stock selection. | Finance |
St. Mary's College (Maryland)
 St. Mary's College (Maryland) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology Operates as a protein biomarker discovery and clinical diagnostics company | Health Technology |
University of Maryland School of Medicine
 University of Maryland School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
Generation Bio Co.
 Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
